Satinder Rawat, Director

Howard Davis, Ph.D., has served as Chief Executive Officer and member of the Board of Directors of Akamis Bio since July 2022. Howard brings more than 20 years of experience to the company having served in diverse roles across both venture capital-backed biotechnology and large pharmaceutical companies. Most recently, he worked with Atlas Venture on the launch of Third Harmonic Bio, a clinical stage immunology company where he served as Chief Operating Officer. During his tenure, he spearheaded fundraising efforts that secured $155 million in private financing to support advancement of the company’s lead molecule.

Earlier in his career, Howard served as a Principal at Flagship Pioneering where he focused on the firm’s corporate strategic partnerships, as well as new company creation efforts. Prior to Flagship, he held roles of increasing responsibility at Biogen and Novartis across a range of functional areas including commercial, manufacturing, pipeline program leadership and corporate strategy. He began his industry career in the healthcare practice at Boston Consulting Group, a management consulting company.

Howard holds a B.S. in Chemical Engineering from Yale and a Ph.D. in biomedical engineering from the Harvard-MIT Division of Health Sciences & Technology. Howard is based in Akamis Bio’s Kendall Square offices in Cambridge, MA.